Rapid and sensitive typing of NPM1 mutations using LNA-mediated PCR clamping

被引：32

作者：

Thiede, C. ^{[1
]}

Creutzig, E.

Illmer, T.

Schaich, M.

Heise, V.

Ehninger, G.

Landt, O.

机构：

[1] Tech Univ, Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 1, Dresden, Germany

[2] CHIPRON GmbH, Berlin, Germany

[3] TIB MOLBIOL GmbH, Berlin, Germany

来源：

LEUKEMIA | 2006年 / 20卷 / 10期

关键词：

D O I：

10.1038/sj.leu.2404367

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1897 / 1899

页数：4

共 8 条

[1] Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. [J].

Falini, B ;

Mecucci, C ;

Tiacci, E ;

Alcalay, M ;

Rosati, R ;

Pasqualucci, L ;

La Starza, R ;

Diverio, D ;

Colombo, E ;

Santucci, A ;

Bigerna, B ;

Pacini, R ;

Pucciarini, A ;

Liso, A ;

Vignetti, M ;

Fazi, P ;

Meani, N ;

Pettirossi, V ;

Saglio, G ;

Mandelli, F ;

Lo-Coco, F ;

Pelicci, P ;

Martelli, MF .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :254-266

[2] Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML [J].

Falini, Brunangelo ;

Bolli, Niccolò ;

Shan, Jing ;

Martelli, Maria Paola ;

Liso, Arcangelo ;

Pucciarini, Alessandra ;

Bigerna, Barbara ;

Pasqualucci, Laura ;

Mannucci, Roberta ;

Rosati, Roberto ;

Gorello, Paolo ;

Diverio, Daniela ;

Roti, Giovanni ;

Tiacci, Enrico ;

Cazzaniça, Giovanni ;

Biondi, Andrea ;

Schnittger, Suzanne ;

Haferlach, Torsten ;

Hiddemann, Wolfgang ;

Martelli, Massimo F. ;

Gu, Wei ;

Mecucci, Cristina ;

Nicoletti, Ildo .

BLOOD, 2006, 107 (11) :4514-4523

[3] Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations [J].

Gorello, P. ;

Cazzaniga, G. ;

Alberti, F. ;

Dell'Oro, M. G. ;

Gottardi, E. ;

Specchia, G. ;

Roti, G. ;

Rosati, R. ;

Martelli, M. F. ;

Diverio, D. ;

Lo Coco, F. ;

Biondi, A. ;

Saglio, G. ;

Mecucci, C. ;

Falini, B. .

LEUKEMIA, 2006, 20 (06) :1103-1108

[4] Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia [J].

Noguera, NI ;

Ammatuna, E ;

Zangrilli, D ;

Lavorgna, S ;

Divona, M ;

Buccisano, F ;

Amadori, S ;

Mecucci, C ;

Falini, B ;

Lo-Coco, F .

LEUKEMIA, 2005, 19 (08) :1479-1482

[5] Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia [J].

Suzuki, T ;

Kiyoi, H ;

Ozeki, K ;

Tomita, A ;

Yamaji, S ;

Suzuki, R ;

Kodera, Y ;

Miyawaki, S ;

Asou, N ;

Kuriyama, K ;

Yagasaki, F ;

Shimazaki, C ;

Akiyama, H ;

Nishimura, M ;

Motoji, T ;

Shinagawa, K ;

Takeshita, A ;

Ueda, R ;

Kinoshita, T ;

Emi, N ;

Naoe, T .

BLOOD, 2005, 106 (08) :2854-2861

[6] Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML) [J].

Thiede, Christian ;

Koch, Sina ;

Creutzig, Eva ;

Steudel, Christine ;

Illmer, Thomas ;

Schaich, Markus ;

Ehninger, Gerhard .

BLOOD, 2006, 107 (10) :4011-4020

[7] Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML):: association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance [J].

Verhaak, RGW ;

Goudswaard, CS ;

van Putten, W ;

Bijl, MA ;

Sanders, MA ;

Hugens, W ;

Uitterlinden, AG ;

Erpelinck, CAJ ;

Delwel, R ;

Löwenberg, B ;

Valk, PJM .

BLOOD, 2005, 106 (12) :3747-3754

[8] LNA (Locked nucleic acid): High-affinity targeting of complementary RNA and DNA [J].

Vester, B ;

Wengel, J .

BIOCHEMISTRY, 2004, 43 (42) :13233-13241

← 1 →